BioSothis

For scientists, by scientists

Tetrahedral framework nucleic acid delivery of emodin enables precision antibacterial and anti-inflammatory therapy for drug-resistant Staphylococcus aureus.

2026-03-22, Journal of Nanobiotechnology (10.1186/s12951-026-04278-5) (online)
Peitong Jiang, Li Wang, Yun Sun, Bingmei Wang, Zhangyu Du, Luanbiao Sun, Dongbin Guo, Xinyao Liu, Han Gao, Yuan Gao, Changfeng Zhu, Yicheng Zhao, and Ye Jin (?)
Staphylococcus aureus skin infections represent a persistent clinical challenge owing to their high pathogenicity, multidrug resistance, and biofilm-associated recurrence, which collectively impair antibiotic penetration and exacerbate host inflammation. Emodin, a natural anthraquinone with dual antibacterial and anti-inflammatory activities, has shown therapeutic promise but suffers from poor solubility, rapid clearance, and a lack of pathogen specificity, limiting its translational potential. Here, we developed a multifunctional nanoplatform composed of tetrahedral framework nucleic acids (tFNAs), in which Emodin was noncovalently loaded onto a DNA scaffold to enable sustained release, and a Staphylococcus aureus-specific aptamer was displayed to enable targeted bacterial recognition. Notably, this aptamer-guided design is pathogen oriented, aiming for bacteria-associated enrichment in infected wounds rather than targeting host inflammatory markers or specific immune cell subsets.
This article has not yet been included in any curations.
 
 
0
   

Comments

There are no comments on this article yet.


You need to login or register to comment.
FAQ | Manual | Privacy Policy | Contact